Logos Global Management LP Pmv Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $28 Million - $42.3 Million	-1,400,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $32 Million - $43.7 Million	1,193,436 Added 577.76%	1,400,000 $41.7 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $183,857 - $236,369	6,564 Added 3.28%	206,564 $7.06 Million
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $3.07 Million - $4.95 Million	100,000 Added 100.0%	200,000 $6.58 Million
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $1.59 Million - $3.08 Million	-50,000 Reduced 33.33%	100,000 $6.15 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $5.33 Million - $5.7 Million	150,000 New	150,000 $5.33 Million

43.4M

500

100

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $79.8M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.